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change in moderate-vigorous physical activity and
sedentary behaviour
Claire L Cleland1,2, Ruth F Hunter1, Frank Kee1, Margaret E Cupples1,3, James F Sallis4 and Mark A Tully1*Abstract
Background: Feasible, cost-effective instruments are required for the surveillance of moderate-to-vigorous physical
activity (MVPA) and sedentary behaviour (SB) and to assess the effects of interventions. However, the evidence base
for the validity and reliability of the World Health Organisation-endorsed Global Physical Activity Questionnaire
(GPAQ) is limited. We aimed to assess the validity of the GPAQ, compared to accelerometer data in measuring and
assessing change in MVPA and SB.
Methods: Participants (n = 101) were selected randomly from an on-going research study, stratified by level of
physical activity (low, moderate or highly active, based on the GPAQ) and sex. Participants wore an accelerometer
(Actigraph GT3X) for seven days and completed a GPAQ on Day 7. This protocol was repeated for a random
sub-sample at a second time point, 3–6 months later. Analysis involved Wilcoxon-signed rank tests for differences in
measures, Bland-Altman analysis for the agreement between measures for median MVPA and SB mins/day, and
Spearman’s rho coefficient for criterion validity and extent of change.
Results: 95 participants completed baseline measurements (44 females, 51 males; mean age 44 years, (SD 14);
measurements of change were calculated for 41 (21 females, 20 males; mean age 46 years, (SD 14). There was
moderate agreement between GPAQ and accelerometer for MVPA mins/day (r = 0.48) and poor agreement for
SB (r = 0.19). The absolute mean difference (self-report minus accelerometer) for MVPA was −0.8 mins/day and
348.7 mins/day for SB; and negative bias was found to exist, with those people who were more physically active
over-reporting their level of MVPA: those who were more sedentary were less likely to under-report their level of
SB. Results for agreement in change over time showed moderate correlation (r = 0.52, p = 0.12) for MVPA and
poor correlation for SB (r = −0.024, p = 0.916).
Conclusions: Levels of agreement with objective measurements indicate the GPAQ is a valid measure of MVPA
and change in MVPA but is a less valid measure of current levels and change in SB. Thus, GPAQ appears to be an
appropriate measure for assessing the effectiveness of interventions to promote MVPA.
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Non-communicable chronic diseases (NCDs) are the
leading causes of morbidity and mortality in both the
developing and developed nations [1-3]. Specifically,
within the United Kingdom (UK) it has been reported
by the World Health Organisation (WHO) that since
2000 they account for 89% of total deaths and the most
common NCDs in order of prevalence are: cardiovascu-
lar diseases, cancers, chronic respiratory diseases and
diabetes [4]. These diseases are associated with a variety
of determinants including physical inactivity, poor nutri-
tional choices, tobacco use and socio-economic status
[1,2,5]. Of note ‘physical inactivity’ describes when some
form of physical activity is performed but not to a level
that would produce a distinct increase in levels of energy
expenditure [6].
In addition, more recent attention has focused on the
health consequences of sedentary behaviour (SB) as a dis-
tinct behaviour, in relation to the development of NCDs
[7]. Sedentary behaviour is often used synonymously with
‘physical inactivity’ although it should be noted that it has
been defined differently as “activities that include energy
expenditure at a level of 1.0-1.5 metabolic equivalent units
(MET)”; for reference, sitting equates to 1.0 MET [8]. Sed-
entary behaviour is commonly measured as time spent sit-
ting (e.g. computer use, working, watching television,
reading) and is considered as a risk factor for cardiovascu-
lar and metabolic disease, independent of time spent in
physical activity (PA) [8-11]. To ensure clarity for public
health-related research, PA has been defined as “any bod-
ily movement produced by skeletal muscles that results in
energy expenditure”; this includes activities of daily life in
work, leisure time, during employment or in the house
[12]. Physical activity can be classified into three inten-
sities: light (1.6-2.9 MET e.g. slow walking, household
chores); moderate (3.0-6.0 MET e.g. walking, golf, light
cycling, dancing); and vigorous (>6.0 MET e.g. football,
tennis, jogging/running, boxing) [13].
Both PA and SB have been recognised as having a vital
role in the prevention and treatment of NCDs [13]. As
both PA and SB are health priorities, it is important to
measure the behaviours with high quality instruments in
both public health practice and research, to provide evi-
dence for informed policy decision making [1,2,14,15].
Considering the potential significance that PA and SB
have for health, the measurement of both behaviours
must be performed using valid and reliable measurement
tools which are consistent on a local, national and inter-
national scale to allow meaningful comparisons of behav-
iour among populations and to determine the effectiveness
of behaviour change interventions [1,15-17].
The Global Physical Activity Questionnaire (GPAQ) was
developed in 2002 by the World Health Organisation
(WHO) as part of the WHO STEPwise Approach toChronic Disease Risk Factor Surveillance for PA observa-
tion [18]. Its use in national surveillance of PA was recom-
mended by the WHO in their 2004 Global Strategy on
Diet, Physical Activity and Health [19]. The GPAQ con-
sists of 16 questions designed to estimate an individual’s
level of PA in 3 domains (work, transport and leisure
time) and time spent in SB [15,20]. Taking into consider-
ation that the GPAQ was initially developed as a surveil-
lance tool, to be used for evaluation and comparison of
PA levels on both a local and international scale, it is im-
portant that the limited evidence base for its validity is fur-
ther developed, particularly for use in behaviour change
interventions [21,22].
GPAQ has been previously assessed in terms of its valid-
ity and reliability in a nine country study implemented by
Bull et al., in 2009, and it was more recently validated in
Malaysian, Vietnamese and American adults [15,22-25].
Evidence for the validity of the GPAQ in European coun-
tries is somewhat lacking and requires further investiga-
tion as it may be influenced by cultural norms, levels of
education, and differences in perceived social desirability
[26]. Previous studies showed that the criterion-related
validity of the GPAQ for moderate intensity PA, as de-
termined by an accelerometer, was poor (South Africa
r = −0.03) and fair (China r = 0.23) (15); comparison of
the GPAQ and accelerometer data for vigorous PA
showed fair criterion-related validity (South Africa r = 0.26
and China r = 0.23) (15). With most prior studies being
conducted in low- to moderate-income countries where
low education could have contributed to lower validity
than expected, GPAQ should be further evaluated in
high-income countries. Moreover, none of the studies
referenced have assessed the validity of the GPAQ in
measuring changes in PA, despite its proposed uses.
Therefore, in a sample of adults residing in the UK the
aims of the current study were to:
1) Assess the criterion validity of the GPAQ
compared to accelerometer data in determining
moderate-to-vigorous physical activity (MVPA)
and time spent in SB.
2) Assess the validity of the GPAQ when estimating
changes in PA and SB over time.
Methods
The study was approved by the Office for Research Ethics
Committees, Northern Ireland (09/NIR02/66).
Participant recruitment
Participants were selected randomly from those who
consented to take part in further research, following
their completion of the 2010/2011 Physical Activity and
the Rejuvenation of Connswater (PARC) Study Household
Survey [26]. For the current study, the aim was to recruit
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across sexes and levels of PA, which, according to Bland
and Altman [27], would allow for 95% confidence intervals
of approximately +/−0.34 standard deviations.
Participants were selected using computer based ran-
dom number generation, with stratification by sex and
by level of PA (high, moderate or low), as determined by
the GPAQ which was a component of the PARC House-
hold Survey, using the GPAQ Analysis Guide [18].
The PA level of each participant was measured be-
tween May and October 2011, and a random sub-sample
(again selected using computer based random number
generation) had their measurements repeated between
November and December 2011 (Figure 1). All partici-
pants provided written informed consent prior to com-
mencing both studies.
Measures of physical activity
At the beginning of each measurement period, study
participants were visited at their home, where the re-
searcher explained the purpose of the study and demon-
strated the use of the Actigraph GT3X accelerometer
(Actigraph Inc., Florida, US). Participants were asked to
wear the accelerometer on their hip for seven consecutive
days and afterwards to complete a GPAQ. Activity countsFigure 1 Flow diagram for participants in validation study (Time 1).were recorded in one second epochs. In order to obtain
total minutes of MVPA per day, the data were reintegrated
in 60 second epochs before Freedson cut off points were
applied to the data: sedentary (≤ 100 counts min−1), light
(101–1951 counts min−1), moderate (1952–5724 counts
min−1) and vigorous PA (≥ 5725 counts min−1) [28,29].
Non-wear time was defined as a run of zero counts
lasting more than 60 minutes [30]. At least five valid
days (including one weekend day) were required for in-
clusion in the analysis; a valid day was defined as a 24-
hour period in which more than 600 minutes of wear
time were recorded [31,32]. At the end of the study
period, the researcher collected the accelerometer and
invited participants to complete the GPAQ again.
Data management
The GPAQ data were entered manually into SPSS Data
Analysis Version 17.0 (SPSS Inc, Chicago, IL). Ten per-
cent of data were checked for accuracy (by CLC) of
entry and results showed 100% accuracy. The GPAQ
data were cleaned and processed using the WHO Steps
programme [18]. Accelerometer data were processed
using ActiLife version 5.2.0. For the purpose of this
study both the GPAQ and accelerometer data were re-
ported as continuous variables (min·d−1).
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Statistical analysis was performed using SPSS Data
Analysis Version 17.0. Independent t-tests were per-
formed to compare baseline demographic variables of
non-participants and participants. Kolmogorov-Smirnov
tests confirmed that the GPAQ data were not normally
distributed (p < 0.05), and data are therefore presented as
medians and inter-quartile range. Differences in the mea-
surements between instruments of 1) median minutes of
MVPA per day and 2) median minutes of SB per day were
assessed using Wilcoxon-signed rank tests.
Using data from time 1 (T1), criterion-related validity
was assessed by comparing minutes of MVPA and SB
per day, as measured by GPAQ, to accelerometer-
determined data, using Spearman’s rho coefficient. Previ-
ous research has identified sex differences in levels of
MVPA [33]. We therefore also repeated the analysis for
males and females separately, to determine if any differ-
ences in validity existed between sexes.
Bland-Altman analysis was performed during the
current study to assess agreement between reported and
objective measures of PA for both minutes of MVPA per
day and minutes of SB per day [27,34]. Bland-Altman
plots were produced using the formulas:
1) Mean [GPAQ minutes of MVPA/day +
accelerometer minutes of MVPA/day]/2 and;
2) Difference [GPAQ minutes of MVPA/day -
accelerometer minutes of MVPA/day].
Limits of agreement were also calculated with the acceler-
ometer data: Mean difference between instruments (GPAQ
minus accelerometer) ± (1.96 × standard deviation).
The extent of change from T1 to time 2 (T2) was
assessed as the difference between measures at T1 minus
T2. Spearman’s rho coefficients were calculated to assess
agreement between the change scores derived from the
two instruments.
To interpret the Spearman’s rho coefficient we used
the following benchmarks: 0–0.20 = poor correlation,
0.21-0.40 = fair correlation, 0.41-0.60 =moderate/acceptable
correlation, 0.61-0.80 = substantial correlation, 0.81-1.0 =
near perfect correlation [35]. Significance was determined
at the level of p <0.05.Results
Demographic characteristics
Of the 345 participants selected to participate, we were
unable to make telephone or postal contact with 115;
129 declined participation (moved house, pregnant, cur-
rently sick, no longer interested). Thus a response rate
of 44% (101/230) for potential participants who were
contacted was achieved for the validation study.There were no statistically significant differences be-
tween participants and those who declined to participate
in age, sex and minutes of MVPA/day (p > 0.05). Of the
101 participants, 6 were excluded from analysis (3 females;
3 males) for either not wearing the accelerometer for the
required period of time (i.e. < 7 days) (n = 3) or failing to
fully complete the questionnaires (n = 3) (Figure 1). Of
the 95 participants who returned data at the end of T1,
44 were female and 51 were male; their mean age was
44 years (SD 14). Of these 95 participants, only 65 (34
female; 31 male) had valid accelerometer wear time
(worn for 600 minutes each day for at least five of the
seven consecutive study days, including one weekend
day); their mean age also was 44 years (SD 14) (Table 1).
Further contact by the research team for the T2 mea-
surements was agreed by 81 of the 101 participants. Of
those, 53 (27 females; 26 males) were selected randomly
to participate in the follow-up study, but we were un-
able to contact 8 participants (Figure 2). Of the 45 who
were contacted, 98% (44/45) agreed to complete T2
measurements; 1 individual declined participation when
re-contacted. Of these 44, 3 males failed to provide a
complete dataset by either not wearing the accelerom-
eter for the required period of time (n = 1) or not fully
completing the questionnaire (n = 2). Of those who
completed the test-retest study (n = 41), 21 were female
and 20 were male, with a mean age of 46 years (SD 14).
Of the 41 participants who completed the second
phase of the study 30 (17 female; 13 male; mean age
48 years (SD13)) had valid accelerometer wear time at
T2 (wore the monitor for 600 minutes each day for at
least five days, including one weekend day). However, 8
of these participants did not have valid accelerometer
wear time at T1, so assessing the extent of change was
possible only for 22 (Figure 2).
Assessment of MVPA
Comparing data from the two instruments at T1 (n = 65)
showed that the median minutes of MVPA measured by
the GPAQ was 30 minutes compared to 56 minutes
measured by the accelerometer. This difference was not
statistically significant overall (p = 0.073); it reached stat-
istical significance for females (p = 0.048), but not for
males (p = 0.544) (Table 2).
A moderate level of agreement between the GPAQ and
accelerometer data for MVPA at T1 (n = 65) was observed
for criterion validity (r = 0.484; p < 0.005). Sub-group ana-
lysis by sex showed similar moderate correlations for cri-
terion validity for females (r = 0.434; p = 0.010) and males
(r = 0.496; p = 0.005) (Table 3).
Results for the Bland-Altman analysis showed that the
difference between the two instruments was 0.8 minutes of
MVPA per day (SD 66.86). The limits of agreement for the
two instruments were wide, with the difference lying
Table 1 Demographic characteristics of participants recruited to the validation (Time 1) and follow-up (Time 2) studies
Time 1 Time 2
Overall sample Valid sample* Overall sample Valid sample*
(n = 95) (n = 65) (n = 41) (n = 30)
Sex N (%) N (%) N (%) N (%)
Female 44 (46) 34 (52) 21 (51) 17 (57)
Male 51 (54) 31 (48) 20 (49) 13 (43)
Age (years), mean (SD)
Overall sample 44 (14) 44 (14) 46 (14) 48 (13)
Female 43 (13) 44 (14) 45 (13) 49 (12)
Male 45 (15) 45 (13) 46 (15) 48 (14)
Physical activity level** N (%) N (%) N (%) N (%)
Low 25 (26) 18 (28) 12 (29) 9 (30)
Females 11 10 7 5
Males 14 8 5 4
Moderate 35 (37) 27 (41) 15 (37) 12 (40)
Females (N) 19 14 8 8
Males (N) 16 13 7 4
High 35 (37) 20 (31) 14 (34) 9 (30)
Females (N) 15 10 6 4
Males (N) 20 10 8 5
*Participants who had valid accelerometer wear time (5 days including one weekend day).
**As reported by GPAQ in previously administered household survey [24].
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ing a review of Figure 3 it would appear that negative bias
exists for the GPAQ with the majority of points falling
below zero. In addition, those people who were more phys-
ically active were found to be more likely to over-report
their level of physical activity using the GPAQ (Figure 3).
The mean (±SD) change in MVPA over the two time
points was 3.55 ± 64.60 mins/day (range −111 mins/day to
223 mins/day) when measured by the GPAQ and −3.05 ±
16.62 mins/day (range −33 mins/day to 47 mins/day)
when measured by the accelerometer. Comparing the ex-
tent of change in MVPA over the two time points (n = 22)
indicated that there was a moderate level of agreement be-
tween the instruments (r = 0.523; p = 0.12) (Table 3).
Assessment of SB
The median minutes of SB from T1 (n = 65) was 300
mins/day as measured by the GPAQ and 696 mins/day
from the accelerometer. This difference was significant
for the overall group (p = 0.0001), females (p = 0.0001)
and males (p = 0.0001) (Table 2).
A non-significant, poor level of agreement between
the GPAQ and accelerometer data for SB at T1 (n = 65)
was observed (r = 0.187; p = 0.135). Sub-group analysis
by sex showed fair level correlations for females (r = 0.378;
p = 0.027) but a poor correlation for males (r = −0.053;
p = 0.778) (Table 4).Results for the Bland-Altman analysis showed that the
difference between the two instruments was −348.7 minutes
of SB per day (SD 190). Limits of agreement for the
two instruments (GPAQ and accelerometer) were wide,
with the difference lying between −721.10 and +23.70
mins/day (Figure 4). Following a review of Figure 4 it
would appear that negative bias exists for the GPAQ
with the majority of points falling below zero. In
addition, following a review of Figure 4 it would appear
that bias exists, and those people who were found to
be more sedentary were less likely to under-report
their level of sedentary behaviour using the GPAQ
(Figure 4).
The mean (±SD) change in SB over the two time
points was 27.73 ± 137.94 mins/day (range −270 mins/
day to 210 mins/day) when measured by the GPAQ and
20.50 ± 75.22 mins/day (range −177 mins/day to 133
mins/day) when measured by the accelerometer. Com-
paring the extent of change in SB over the two time
points (n = 22) indicated a poor level of agreement be-
tween the instruments (r = −0.024; p = 0.916) (Table 4).
Discussion
Validity of GPAQ assessment of MVPA
The results demonstrate moderate evidence of criterion-
related validity for the GPAQ when compared with ac-
celerometer minutes of MVPA (r = 0.484). The levels of
Recruited from validation study (T1) for test-retest 
study (T2)
(n = 81)
Randomly sampled for invitation to test retest study
(T2)
(n = 53) 
Females (27)
Males (26)
Declined participation 
(n = 1)
Withdrawn (1)
Accepted 
(n = 44)
Females (21)
Males (23)
Could not be contacted 
(n = 8)
No response to 
telephone call (6)
Phone number not in 
use (2)
Did not complete 
(n = 3 males)
Did not complete 
questionnaire (2)
Did not wear 
accelerometer (1)
Completed (n = 41)
Females (21)
Males (20)
Valid wear time T2 
(n = 30) 
Females (17)
Males (13)
Valid wear time 
T1 & T2 
(n = 22)
Females (14)
Males (8)
Figure 2 Flow diagram for participants in test retest study (Time 2).
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by Herrmann et al. [22] (USA r = 0.26) were substantially
higher than the highest correlations found for moderate
PA in low-income countries reported by Bull et al. [15]
(South Africa (r = −0.03) and China (r = 0.23)). HigherTable 2 Assessment of minutes of MVPA per day and time sp
GPAQ and accelerometer at Time 1
Measurement tool Median MVPA
per day (mins)
Inter quartile range T-test of d
Validation study (n = 65)
GPAQ 30 17-75 p = 0
Accelerometer 56 44-74
Females (n = 34)
GPAQ 30 15-62 p = 0
Accelerometer 49.5 44-66
Males (n = 31)
GPAQ 43 19-120 p = 0
Accelerometer 65 48-76validity of GPAQ in higher-income countries is likely
due to high education levels. Some discrepancies can
occur between self-report measures and accelerometers,
as accelerometers do not register all upper body move-
ments e.g. swimming and cycling [17]. This could be anent in sedentary behaviour per day as measured by
ifference Median sedentary
time per day (mins)
Inter quartile range T-test of
difference
.073 300 180-435 p = 0.0001
696 617-751
.048 240 180-360 p = 0.0001
660 613-719
.544 360 180-480 p = 0.0001
715 627-776
Table 3 Moderate-to-vigorous physical activity (mins/day): Spearman’s rho coefficient correlations for the GPAQ vs
accelerometer
Sample n Variables Time point Spearman’s rho coefficient (r) p value
Criterion validity
Overall sample* 65 GPAQ vs. Accelerometer (mins/day MVPA) Time point 1 0.484 0.000
Females 34 0.434 0.010
Males 31 0.496 0.005
Extent of change
Overall sample** 22 Change between T1 and T2: Time point 1 vs. Time point 2 0.523 0.12
GPAQ vs. accelerometer (mins/day MVPA)
*Overall sample that had valid accelerometer wear time (validation study; T1) (65/95).
**Overall sample that had valid accelerometer wear time (T1 and T2) (22/41).
MVPA: moderate-to-vigorous physical activity.
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with results from South Africa and China, because work
related PA in the latter countries is more commonly as-
sociated with upper body movements [16,23]. Present
validity estimates for GPAQ were slightly higher than esti-
mates based on similar methods with the widely used
International Physical Activity Questionnaire (IPAQ) [29].
Although GPAQ had a moderate correlation with ac-
celerometer for minutes of MVPA per day, the inter-
quartile range was wide for the GPAQ in comparison to
the narrower range found for the accelerometer. There-
fore, at the level of the individual where a precise meas-
urement may be required, the GPAQ may not offer aFigure 3 Bland-Altman plots of minutes of MVPA per day between thedesirable degree of precision, meaning that GPAQ may not
be an appropriate tool for assessing an individual’s level of
PA. This finding concurs with the recommendation by
Ekelund et al. who suggested that self-reported physical ac-
tivity in general was not sufficiently accurate for individual
assessment [36].
A relatively novel finding was the moderate correlation
between the GPAQ and accelerometer for the extent of
change in minutes of MVPA/day. Though PA self-
reports are widely used to evaluate interventions, they
are rarely validated in their ability to detect change.
Therefore, whilst the GPAQ might not be considered an
appropriate tool to measure the effectiveness of aGPAQ self-report questionnaire and Actigraph GT3X accelerometer.
Table 4 Sedentary behaviour (min/day): Spearman’s rho coefficient correlations for the GPAQ vs accelerometer
Sample n Variables Time point Spearman’s rho coefficient (r) P value
Criterion validity
Overall sample* 65 GPAQ vs. Accelerometer (mins/ day) Time point one 0.187 0.135
Females 34 0.378 0.027
Males 31 −0.053 0.778
Extent of change
Overall sample** 22 Change between T1 and T2: Time point one vs. Time point two −0.024 0.916
GPAQ vs. accelerometer (mins/day SB)
*Overall sample that had valid accelerometer wear time (validation study; T1) (65/95).
**Overall sample that had valid accelerometer wear time (T1 and T2) (22/41).
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ual, it would be acceptable to measure effectiveness at
the level of a community or population, using minutes
of MVPA/day as the outcome measure.
Validity of GPAQ assessment of SB
The results of the current study showed that a signifi-
cantly higher level of SB was measured by the acceler-
ometer than was self-reported by participants using the
GPAQ. This finding is similar to that of a recent study
by Clemes et al. who found that when a self-report
measure of SB was comprised of a single SB item (true
for the GPAQ) it significantly underestimated SB in
comparison to accelerometer data [37]. Our finding of aFigure 4 Bland-Altman plots of minutes of sedentary behaviour per d
GT3X accelerometer.poor correlation (r = 0.187) between GPAQ measure-
ment for minutes of SB per day and accelerometer data
concurs with previous studies [38], though validity find-
ings with the IPAQ sitting items were higher for both
long (r = 0.33) and short (r = 0.34) forms [39].
Developing accurate and valid methods of SB measure-
ment is important for this growing area of research, both
for epidemiological and intervention studies [40]. Measur-
ing SB is challenging, and more research is needed par-
ticularly when aiming to distinguish between behaviours
such as lying down, sitting or standing [37,40-42].
Present findings demonstrate that GPAQ may not be
appropriate when assessing minutes of SB or SB change
after an intervention in an individual or a population.ay between the GPAQ self-report questionnaire and Actigraph
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using a multiple item domain-specific questionnaire or
an objective measurement tool that can distinguish be-
tween postures [37,40].
Strengths and limitations
This study had several strengths including the concord-
ant measurement period for each of the tools (same
7 days), the rigour that was applied during the sampling
process and a sample of individuals stratified by their
physical activity level, which improves the generalisabil-
ity of the findings.
Limitations included the small sample size, especially
for analyses of change that resulted from invalid acceler-
ometer data and incomplete self-report questionnaires.
The required sample size for both study components, to
give a 95% confidence interval of approximately +/−0.34
standard deviations [27], is 100 individuals, which we
did not achieve due to loss of data following cleaning.
This limitation was also found by Prince et al. who re-
corded inconsistencies and time lags between the num-
ber of days that were assessed by the self-report and
objective physical activity measures [17]. However the
current study was larger than previous analyses of the
validity of GPAQ [22].
The gold standard for the measurement of free living
energy expenditure is doubly labelled water (DLW) [43],
but this is an expensive tool to implement, requires
trained professionals to manage its implementation and
has high levels of both participant and researcher bur-
den [44]. Therefore in this study, an accelerometer has
been used as a viable, practical and acceptable alterna-
tive. Accelerometers have previously been shown to be
reliable and validated against DLW, making the acceler-
ometer an acceptable criterion device for use in this
study [43,44].
Our review of previous research indicated that the
Actigraph GT3X was the most appropriate commercially
available accelerometer for our study. This particular
model has been shown to be a valid and reliable tool, ap-
proved for use in clinical and epidemiological studies to
measure PA in free living populations [45] and found to
have a good level of inter-instrument reliability [46]. In
addition, Actigraph has previously been reported as the
“only commercially available accelerometer that has re-
peatedly been shown to significantly correlate with
DLW-derived energy expenditure” [44].
However, accelerometers have their limitations. For ex-
ample, an accelerometer does not measure water based
activities or non-ambulatory activities such as cycling, so
they may therefore underestimate MPVA [47]. On the
other hand, self-reported measurement methods have
their own limitations as they are prone to biases such as
recall and social desirability [48]. Therefore, it may beappropriate to propose the use of both a subjective and an
objective measurement tool, whenever possible, to obtain
an assessment of PA type, intensity, duration, context and
location [42]. Implementing a composite PA measurement
strategy would ensure that the inadequacies of self-report
and objective tools individually are compensated for by
the other.Conclusion
In conclusion, the present study adds important new
data on the validity of the widely-used GPAQ in a high-
income country for estimating PA and SB levels as well
as evaluating change. Overall the results suggest that the
self-report GPAQ may be used appropriately to estimate
levels of MVPA and monitor change in MVPA in a
population sample and thus to assess the effectiveness of
PA interventions on a community or population level.
However present results suggest the GPAQ is not a valid
measure of time spent in SB or change in SB over time
in healthy free living adults.
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